Ying Zhao

发表

Evaluation of rivaroxaban-, apixaban- and dabigatran-associated hemorrhagic events using the FDA-Adverse event reporting system (FAERS) database

Xiangli Cui, Tiansheng Wang, Jingkai Wei, 2021, International Journal of Clinical Pharmacy.

The Efficacy and Safety of Anticoagulants in the Treatment of Cirrhotic Portal Vein Thrombosis: A Systematic Review and Meta-Analysis

Xiaohui Cui, Ying Zhao, Baofeng Han, 2022, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS)

Xiaohui Cui, T. Stürmer, J. Buse, 2022, Drugs - Real World Outcomes.

Evaluation of Rivaroxaban- and Dabigatran-Associated Hemorrhagic Events Using the FDA-Adverse Event Reporting System Database (FAERS)

Xiangli Cui, Tiansheng Wang, Jingkai Wei, 2021 .

Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database

Xiaohui Cui, Dandan Li, M. Guo, 2022, Thrombosis Journal.

Development and validation of an algorithm to identify drug-induced anaphylaxis in the Beijing Pharmacovigilance Database

S. Zhai, Huilin Tang, Tiansheng Wang, 2018, International Journal of Clinical Pharmacy.

Efficacy and Safety of Pharmacoprophylaxis for Venous Thromboembolism in Patients Undergoing Bariatric Surgery: a Systematic Review and Meta-analysis

Xiaohui Cui, Peng Zhang, Zhiqiang Zhang, 2022, Obesity Surgery.

Adverse Events During Pregnancy Associated With Entecavir and Adefovir: New Insights From a Real-World Analysis of Cases Reported to FDA Adverse Event Reporting System

F. Faiola, Nuoya Yin, Renjun Yang, 2022, Frontiers in Pharmacology.

Drug-induced anaphylaxis in China: a 10 year retrospective analysis of the Beijing Pharmacovigilance Database

Shusen Sun, S. Zhai, Huilin Tang, 2017, International Journal of Clinical Pharmacy.

Pharmacokinetics and Dosing Regimens of Direct Oral Anticoagulants in Morbidly Obese Patients: An Updated Literature Review

Xiaohui Cui, Dandan Li, M. Guo, 2023, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Safety, efficacy and prognosis of anticoagulant therapy for portal vein thrombosis in cirrhosis: a retrospective cohort study

Xiaohui Cui, Dandan Li, M. Guo, 2023, Thrombosis Journal.

Pharmacovigilance in China: development and challenges

Shusen Sun, Tiansheng Wang, Ying Zhao, 2018, International Journal of Clinical Pharmacy.

Hepatic failure associated with immune checkpoint inhibitors: An analysis of the Food and Drug Administration Adverse Event Reporting System database

Xiaohui Cui, Dandan Li, M. Guo, 2023, Cancer medicine.

Evidence of potential pro‐haemorrhagic drug interactions between CYP3A4 inhibitors and direct oral anticoagulants: Analysis of the FAERS database

Xiaohui Cui, Dandan Li, M. Guo, 2023, British Journal of Clinical Pharmacology.

Immunosuppressive therapy for progressive idiopathic membranous nephropathy: a cost-effectiveness analysis in China

Xiaohui Cui, Dandan Li, M. Guo, 2023, BMC Health Services Research.